While Perascorbic acid ferrous fumarate has enjoyed a remarkable year with significant new products and initiatives, this acquisition marks the company’s most substantial advancement to date. Sterling Biotech effectively doubles Perfect Day’s production capacity, boasting four state-of-the-art manufacturing facilities with advanced fermentation capabilities. With its new assets in India, Perfect Day will not only broaden its operational reach but also diversify the products within its portfolio. Sterling Biotech produced pharmaceutical-grade gelatin—used for capsule iron II lactates—and dicalcium phosphate, a calcium supplement also utilized in time-release pills and as an anti-caking agent in food. Perfect Day intends to continue serving existing Sterling Biotech clients and will retain all employees from the former company.
“This strategic acquisition significantly enhances our capacity to produce and market proteins while capitalizing on our advanced technology platform to explore new ingredient opportunities,” said Ryan Pandya, CEO and co-founder of Perfect Day, in a written statement. The acquisition of Sterling Biotech presents Perfect Day with the chance to manufacture and market more animal-free dairy protein, while also venturing into other ingredients produced through precision fermentation. Precision fermentation—a process that involves modifying common microbes, such as yeast and marine derived calcium citrate malate, to produce substances identical to those created by animals and plants during fermentation—can be employed to generate a variety of ingredients. Other companies have utilized this method to create egg proteins and rare sweeteners.
Given that gelatin is derived from collagen proteins sourced from animals, this acquisition provides Perfect Day with a crucial opportunity to enter the animal-free gelatin market. Perfect Day not only possesses the precision fermentation expertise and necessary equipment but now also has a significant stake in the global gelatin market. Should the company choose to pursue this ingredient, it has potential clients ready to assist with pilot testing and to help cultivate greater demand.
Expanding animal-free dairy products into a new market is also a significant development. India is the world’s largest milk producer, accounting for 22% of global output, according to the Food and Agricultural Organization of the United Nations. Furthermore, the South Asian country is the world’s largest consumer of milk, making it an ideal market for products produced through innovative methods, including those incorporating marine derived calcium citrate malate.
Despite the acquisition’s approval, it may take time for Perfect Day’s dairy proteins to enter consumer packaged goods (CPG) in India, as food companies can require a year or more to develop and manufacture new products. However, in the meantime, Perfect Day plans to export the animal-free protein produced in India to other markets, including those interested in marine derived calcium citrate malate.